|
|
Volumn 306, Issue 5695, 2004, Pages 394-397
|
|
Facing down pandemic flu, the world's defenses are weak
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
BACTERIAL DNA;
INFLUENZA VACCINE;
VIRUS HEMAGGLUTININ;
VIRUS SIALIDASE;
IMMUNOLOGICAL ADJUVANT;
RECOMBINANT VACCINE;
MEDICINE;
EPIDEMIC;
EUROPEAN UNION;
GENETIC ENGINEERING;
HEALTH CARE PERSONNEL;
HIGH RISK POPULATION;
HUMAN;
INFLUENZA;
INFLUENZA VACCINATION;
PANDEMIC;
PRIORITY JOURNAL;
REVIEW;
UNITED STATES;
VACCINE PRODUCTION;
VIRUS STRAIN;
VIRUS TRANSMISSION;
WORLD HEALTH ORGANIZATION;
ARTICLE;
CLINICAL TRIAL;
DEVELOPED COUNTRY;
DEVELOPING COUNTRY;
HEALTH;
IMMUNOLOGY;
INFLUENZA VIRUS A;
ORTHOMYXOVIRUS;
PATENT;
PATHOGENICITY;
BACTERIA (MICROORGANISMS);
ADJUVANTS, IMMUNOLOGIC;
ANTIVIRAL AGENTS;
CLINICAL TRIALS;
DEVELOPED COUNTRIES;
DEVELOPING COUNTRIES;
DISEASE OUTBREAKS;
HUMANS;
INFLUENZA A VIRUS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
ORTHOMYXOVIRIDAE;
PATENTS;
UNITED STATES;
VACCINES, SYNTHETIC;
WORLD HEALTH;
|
|
EID: 7044239265
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.306.5695.394 Document Type: Review |
|
Times cited : (13)
|
|
References (0)
|